POU3F3, also known as Brain-1 (Brn-1), is a transcription factor primarily involved in the development and functioning of the nervous system. POU3F3 (Brn-1) Activators include a variety of small molecules, biochemicals, and potential signaling pathway modulators that can up-regulate the expression or activity of POU3F3. For instance, Histone Deacetylase Inhibitors (HDACIs) like Trichostatin A or Vorinostat can make chromatin structures more accessible, thus facilitating the transcription of genes including POU3F3. Wnt Pathway Modulators, such as CHIR99021, a GSK3β inhibitor, could influence POU3F3 expression by regulating the Wnt/β-catenin pathway. Other molecules like cAMP elevators and DNA Methyltransferase Inhibitors may also play a role in influencing POU3F3 expression by altering intracellular signaling or epigenetic states, respectively.
Although the chemical class of POU3F3 Activators is diverse, they generally share the ability to influence transcriptional or post-translational mechanisms that lead to enhanced POU3F3 expression or activity. GABA Receptor Modulators like phenobarbital can influence neural development and neurotransmission, thereby indirectly affecting POU3F3 expression. Some activators might function through intracellular signaling pathways, such as the PI3K/Akt pathway, which is known for its role in cellular survival and growth. Another group of molecules, like retinoic acid, can influence POU3F3 expression in a context-dependent manner, typically related to neural differentiation. Importantly, the specificity and effectiveness of these activators often require validation and characterization to understand the nuances of their action on POU3F3.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone Deacetylase Inhibitors could increase gene expression by causing a more relaxed chromatin structure, making it more accessible for transcription machinery. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone Deacetylase Inhibitors could increase gene expression by causing a more relaxed chromatin structure, making it more accessible for transcription machinery. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Wnt Pathway Modulators, could potentially activate the Wnt/β-catenin pathway, which in turn could positively influence the expression of neural transcription factors like POU3F3. | ||||||
Muscimol | 2763-96-4 | sc-200460 sc-200460A | 5 mg 25 mg | $161.00 $537.00 | 2 | |
GABA Receptor Modulators could indirectly impact POU3F3 expression through their influence on neural development and neurotransmission. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, which raises intracellular cAMP levels, might positively regulate POU3F3 expression through activation of Protein Kinase A (PKA). | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA Methyltransferase Inhibitors could theoretically up-regulate POU3F3 by demethylating its promoter region, making it more accessible for transcription. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
JAK-STAT Pathway Activators could potentially have an impact on POU3F3 through the activation of the JAK-STAT signaling pathway, although the specificity of such effects would need to be confirmed. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid Receptor Agonists could potentially influence POU3F3 through GRE (glucocorticoid response elements), although the exact relationship would be context-dependent. | ||||||